Wedbush Raises Price Target on MAP Pharmaceuticals (MAPP), Encourages Investors to Buy Due to Possible Takeover
Tweet Send to a Friend
Wedbush is maintaining its Outperform rating on shares of MAP Pharmaceuticals (NASDAQ: MAPP) and is raising its price target by ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
